Science

A Perspective on the MARS2 Trial, by Eric Lim

Eric Lim/vjoncology.com

Jan 15, 2025, 14:23

A Perspective on the MARS2 Trial, by Eric Lim

Oscar Tahuahua, Medical Oncology fellow at Instituto Nacional de Cancerología, shared an article by Eric Lim on X:

“A Perspective on the MARS2 Trial.

Is mesothelioma a surgical disease?

The MARS2 trial shows higher mortality and adverse events without improving survival. Risks increase outside high-volume centers, limiting benefits to specific subgroups.”

A Perspective on the MARS2 Trial.

Authors: Eric Lim, et al.

A Perspective on the MARS2 Trial, by Eric Lim

cancer Eric Lim fight against cancer Global fight against cancer Instituto Nacional de Cancerología MARS2 Trial MedOnc mesothelioma OncoDaily Oncology Oscar Tahuahua

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage